Arkolith/Insider Trading/SNTI/Form 4

Lu Timothy K

CEO, DirectorSenti Biosciences, Inc. (SNTI) · full profile →Form 4 · filed Feb 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2025Sell(S)545$4.36$2K82K
Feb 4, 2025Sell(S)4K$4.07$16K83K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001854270-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML